for Sep 12, 2020 through Sep 18, 2020
1/ “Heavy exposure of children aged 9 to 12 years with SARS-CoV-2 did not lead to infection” Journal of the Pediatric Infectious Diseases Society, September 12, 2020 https://t.co/r7Fm7eq5UX
— Andrew Bostom (@andrewbostom) September 17, 2020
Belgium’s Prof. Jean-Luc Gala, MD, a Top Specialist in Infectious Diseases, says that the rise in infections is not worrying, is completely normal and that it isn’t dangerous for the virus to circulate. He is calling for a COVID herd immunity strategy. https://t.co/PyLcNQrIoM
— Daniel Levitt (@daniellevitt22) September 15, 2020
National Institute of Allergy and Infectious Diseases Director Dr. Anthony Fauci said he believes a coronavirus vaccine may be proven safe and effective by November or December of this year https://t.co/NEIR2apDNW
— CNN (@CNN) September 16, 2020
This week on the Podcast - my best ever! @Laurie_Garrett, Pulitzer Prize-winning journalist on infectious diseases and @ASlavitt, former head of Medicare & Medicaid on every aspect of the coming vaccine. It's harrowing!
— Al Franken (@alfranken) September 13, 2020
Subscribe on Apple Podcasts: https://t.co/cJzn4GnJET pic.twitter.com/WvUjHwZxSD
Infectious Diseases at that time, he likely knew of HCQ’s effectiveness in fighting coronaviruses as early as 2005.
— Tracy Beanz (@tracybeanz) September 16, 2020
READ MORE: https://t.co/rN09gpoyEe
Do you miss travel? I miss travel. But 2 new papers in @CDCgov's journal Emerging Infectious Diseases point out why some of us are unlikely to take to the air for while. #Covid19 transmission on planes. https://t.co/C9VDhInQQe and https://t.co/RF7b9Bl43S
— Helen Branswell (@HelenBranswell) September 18, 2020
NEW 🔥 #OFID @ClaeysKcclaeys @emilylheil
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 13, 2020
Management of Gram-negative Bloodstream Infections in the Era of Rapid Diagnostic Testing: Impact with and without Antibiotic Stewardship. #IDTwitter
RDT + ASP + IDC = ⭐ https://t.co/o41fxNjNQH pic.twitter.com/S8VQ9juoH4
People who volunteer for ethically done, scientifically sound clinical research studies are some of our society's unsung heroes. Well done, @MollyJongFast. 👏👏👏
— Paul Sax (@PaulSaxMD) September 17, 2020
I Am the Joan of Arc of Coronavirus Vaccine Trials https://t.co/dQWhtZuvTo
1. Dr. Scott Atlas, a radiologist with no background in public health, epidemiology or infectious diseases who joined President Trump’s coronavirus response, hired attorney Marc Kasowitz to intimidate a group of Stanford doctors and researchers.https://t.co/NYdVK2YW2w
— The Intellectualist (@highbrow_nobrow) September 17, 2020
Question for the randomized controlled trial nazis that have proliferated since COVID:
— Covid19Crusher (@Covid19Crusher) September 14, 2020
what percentage of the guidelines of the Infectious Diseases Society of America are based on RCTs?
The answer is 14% according to the study below.
Medicine is not RCTs.https://t.co/do9G5J3Flm pic.twitter.com/CNWmvsAiLt
Now more than ever, it's important that we prioritize antimicrobial stewardship. We can’t forget that this, too, is a global health crisis.
— IDSA (@IDSAInfo) September 13, 2020
Our new AMR guidance offers advice for the clinical treatment of 3 of the most common drug-resistant pathogens: https://t.co/DX5CN3YNJp
Important figures from updated @bmj_latest article:Drug treatments for #COVID19 : living systematic review and network meta-analysis.
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 12, 2020
Figure below presents a summary of the effects of the interventions on the outcomes. https://t.co/xMS09vCVul pic.twitter.com/VuXezi5UlP
The Ramon S. Ang Foundation is set to build a state-of-the-art hospital specializing in infectious diseases research on a three to five-hectare property in the southern part of Luzon https://t.co/psF2fs8GBR
— CNN Philippines (@cnnphilippines) September 13, 2020
🔥🔥Very interesting🔥🔥
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 17, 2020
Challenging ‘dogma’ Cefazolin in MSSA IE
Comparative outcomes of cefazolin versus anti-staphylococcal penicillins in MSSA infective endocarditis: a post-hoc analysis of a prospective multicentre French cohort study. #IDTwitter https://t.co/Yjvt813SrK pic.twitter.com/9dWUdatJLs
No role for prophylactic antibiotics or probiotics in the treatment of Acute pancreatitis
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 16, 2020
A Masterpiece Review Article @MarcBesselink of management of Acute pancreatitis @TheLancet #IDTwitter https://t.co/JZ267ZQLpY pic.twitter.com/vaxRmwgCcM
Most antimicrobial stewardship efforts are focused on hospitals, not primary care.
— Madhu Pai (@paimadhu) September 16, 2020
2 studies show high levels of antibiotic over-prescription for conditions that are common in primary carehttps://t.co/gTM8PJa7ku via @PLOSMedicine https://t.co/fXxSmhxikZ via @GlobalHealthBMJ pic.twitter.com/XQy16LRw8x
The AAAAI joined the IDSA requesting the Centers for Medicare and Medicaid Services (CMS) require that U.S. hospitals include verification of penicillin allergy as part of mandatory antibiotic stewardship programs (ASPs). https://t.co/IQzQRGj70T
— Eric Macy (@EricMacyMD) September 17, 2020
NEW 🔥🔥#CID
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 14, 2020
Clinical Experience of Implementing Oral Versus Intravenous Antibiotics (OVIVA) in a Specialist Orthopedic Hospital.
Real world practice #IDTwitter https://t.co/e55eCTiX9f pic.twitter.com/JoRUnJ8Kse
Cefiderocol as rescue therapy for Acinetobacter baumannii & other carbapenem resistant Gram-Negative infections in ICU patients. #IDTwitter #CID https://t.co/W5z8PA0nhg
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 17, 2020
As coronavirus vaccine trials struggle to get minority participation, a group formed by the National Institute of Allergy and Infectious Diseases has unveiled an ad campaign urging Black and Latino people to get involved. https://t.co/mH78szQ17Q
— NBC News (@NBCNews) September 12, 2020
one positive side effect among the many negative ones of lockdown & social distancing & masks etc is that what works for COVID also works for other infectious respiratory diseases... like flu! https://t.co/FElSLmzne6
— Christina Pagel (@chrischirp) September 17, 2020
There are times when I just think, ‘I am so over this pandemic.’ It’s exhausting. You have to show up and be present. I tell myself that I’m not giving up and I won’t let this get the best of me. ” Aileen A. – Antimicrobial Stewardship Pharmacisthttps://t.co/OGGEyHn4mL pic.twitter.com/aTSodExPet
— Hennepin Healthcare (@HennepinHC) September 12, 2020
Revive Therapeutics Announces IRB Approval of US Expanded Access Treatment Program (Compassionate Use) for Bucillamine in COVID-19 | $RVV #covid19 #coronavirus #infectiousdiseases #clinicalstudy #medicalindustry #psilocybin #bucillamine #pharmaceutical | https://t.co/TnNhEzxMwu
— Revive Therapeutics (@Revive_RVV) September 16, 2020
Viruses are key drivers of evolution and ecosystem function, but viruses infecting early-diverging lineages of fungi have been almost entirely unstudied. In @mBioJournal, researchers report mycovirus diversity and abundance using two approaches. https://t.co/PnDKtclt8S pic.twitter.com/tusaWDkaIr
— ASM (@ASMicrobiology) September 16, 2020
People who attend a place of worship often may be more likely to test positive for COVID-19, according to a recent study published in the journal Clinical Infectious Diseases. https://t.co/20zhoDQJBv pic.twitter.com/5Tf7vo6ORH
— WebMD (@WebMD) September 15, 2020
Transmission of SARS-CoV-2: A Review of Viral, Host, and Environmental Factors | @AnnalsofIM https://t.co/6g2yoQGWQA. Fantastic paper by @PaulSaxMD @RMKGandhi and colleagues summarizing the state of knowledge of #SARSCoV2 transmission. A “must read”.
— Carlos del Rio (@CarlosdelRio7) September 17, 2020
The lasting misery of #coronavirus long-haulers https://t.co/cTMc8q7t7S the disease is so new so “to assess long-term consequences, the only thing you need is time.”
— Carlos del Rio (@CarlosdelRio7) September 14, 2020
A man to match the job. "Atlas, a neuroradiologist who has no training in infectious diseases, public health or epidemiology, recently joined the White House coronavirus task force" https://t.co/prxTmeOy65
— Harry Shearer (@theharryshearer) September 18, 2020
Great study of nosocomial #COVID19 in a hospital with (VERY) robust infection prevention measures: there was only 1 nosocomial case across 9,149 admitted patients over a 12 week period (!!) 🔥
— Mike Stevens (@Dr_Mike_Stevens) September 17, 2020
Need to keep focused on/investing in infection prevention!!!https://t.co/BdcVlN01mx pic.twitter.com/kDbK1aneYU
🔥Excellent RCT 🔥@TheLancetInfDis
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 16, 2020
Disappointing results!
In adults at risk for CDI difficile a bivalent C difficile toxoid vaccine did NOT prevent CDI.
The study was terminated after the first planned interim analysis because of futility. #IDTwitter https://t.co/UVrHzYfMrk
A superb special issue of Annals of Epidemiology on #COVID19 edited by @pssinatl with "must read" articles on the racial/ethnic disparities in COVID19 https://t.co/sE9ahZrNyI
— Carlos del Rio (@CarlosdelRio7) September 12, 2020
🔥News release 🔥
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 16, 2020
Lilly announces proof of concept data from an interim analysis of the BLAZE-1 RCT showing a reduced rate of hospitalization for symptomatic #COVID19 patients in the outpatient setting treated with LY-CoV555 " Lucky triple 5 "https://t.co/HzGqYk0l2r pic.twitter.com/07l6PjX0yB
🔥Very interesting🔥 #OFID by Dr. Daniel Musher
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 16, 2020
Normal Respiratory Flora as a Cause of Community-Acquired Pneumonia
A causative organism could be identified in >95% of patients hospitalized for CAP. #IDTwitter https://t.co/v9JUlc41up pic.twitter.com/3OqHCNoJQo
Minireview of progress in the structural study of #SARSCoV2 proteinshttps://t.co/XdODRU7MkQ #coronavirus #COVID19 pic.twitter.com/pgvwaCQXKb
— Microbes&Infection (@MicrobesInfect) September 15, 2020
👏 UAB receives IDSA Antimicrobial Stewardship Centers of Excellence Designation https://t.co/yWTAlkqzMf pic.twitter.com/2WJhEjwliT
— UAB Medicine (@uabmedicine) September 17, 2020
🔥Very Interesting🔥
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 18, 2020
A new large retrospective study suggests that piperacillin/tazobactam + teicoplanin is associated with a higher prevalence of AKI compared with monotherapy.#IDTwitter #JACnews @BSACandJAC https://t.co/7gLPAZwq5F pic.twitter.com/777frhtXzX
Congrats to @UUtah researchers for their outstanding contributions to important #COVID19 research. To date, our faculty have published dozens of COVID-19-related articles in peer-reviewed journals & have received >$10M in grant funding. @UofUHealthhttps://t.co/PKe08BIOWW
— Michael L. Good, MD (@MikeGoodMD) September 15, 2020
Rapid AST testing in Gram-negative rod bacteremia led to improved antibiotic stewardship measures but did not impact length of stay and other clinical outcome measures. @JClinMicro #ASMClinMicro https://t.co/AxcEq3El3c pic.twitter.com/yAjIRnOZjE
— ASM (@ASMicrobiology) September 15, 2020
Drug treatments for covid-19: living systematic review and network meta-analysis | @bmj_company 35 trials with 16,588 patients included. Glucocorticoids “probably” ⬇️ mortality; RDV “probably” ⬇️ duration of symptoms; HCQ has no effect in ether. https://t.co/03R5Y4eJRA
— Carlos del Rio (@CarlosdelRio7) September 14, 2020
Bacterial communities in fungus gardens play a pivotal role in alleviating the effect of plant secondary compounds on the leaf-cutter ant system. @mBioJournal https://t.co/zzY8xohq1S pic.twitter.com/UAVBMTvMxa
— ASM (@ASMicrobiology) September 18, 2020
Interactions b/w influenza A virus and bacterial species of the upper respiratory tract promotes the stability and infectivity of IAV during desiccation stress and suggests a potential role for these respiratory communities in IAV transmission. @mSystemsJ https://t.co/fzWcYb0qGt pic.twitter.com/Dzq2tS7ofH
— ASM (@ASMicrobiology) September 14, 2020
#STUDY, 2011: #MMR vaccine effectiveness ranged from 49-82% after 1 dose & 66-88% after 2 doses, w/ accumulating evidence of WANING immunity over timehttps://t.co/99s4P4he4U
— LotusOak (@LotusOak2) September 15, 2020
Due to vaccination childhood infectious diseases are pushed into adulthood. pic.twitter.com/r8W1Gi3o8J
Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, discussed public health and scientific challenges of COVID-19 at this week’s Harvard Medical Grand Rounds. Watch the recording here: https://t.co/KvNp3YMDVN pic.twitter.com/hrWWkbnTAz
— Harvard Medical School (@harvardmed) September 12, 2020
Congratulations, Dr. Margaret Taylor for receiving the Antimicrobial Stewardship Fellowship Award from @PIDSociety for a dual-center review of #penicillin #allergy #labels in #Children under the mentorship of Dr. Debra Palazzi: https://t.co/Mtm4XMWuKb pic.twitter.com/1pr5oDdhOW
— TCHResearchNews (@TCHResearchNews) September 17, 2020
New research Article: Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trial https://t.co/c821zqwVtF #Cdiff
— The Lancet Infectious Diseases (@TheLancetInfDis) September 16, 2020
Interesting - a new method for combating antibiotic resistance in microbes https://t.co/Q4DtuQmQsq
— BSAC (@BSACandJAC) September 17, 2020
One more reason to delabel.
— Eric Macy (@EricMacyMD) September 17, 2020
Preoperative Allergy Testing for Patients Reporting Penicillin and Cephalosporin Allergies is Cost-Effective in Preventing Infection after Total Knee and Hip Arthroplasty https://t.co/tg5Tj3LLw5
Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19:Serologic Testing https://t.co/VXveH64hHk pic.twitter.com/SYs7Af1R6a
— Ilan Schwartz MD PhD (@GermHunterMD) September 12, 2020
According to the CDC’s own journal, Emerging Infectious Diseases, in May 2020: “Our systematic review found no significant effect of face masks on transmission of laboratory-confirmed influenza.” 🤡🤡🤡https://t.co/C3ZayBVRTE
— EpigeneticWhispereer or Bodhisattva In Training (@EpigeneticWhisp) September 12, 2020
Heard a radio interview with @hans_kluge yesterday talking about “covid fatigue”. I am feeling this amongst colleagues and outside of work. Now is the time to encourage one another and redouble our efforts to prevent #coronavirus spread #HandsFaceSpace https://t.co/hapNndGUl4
— Jon Otter (@jonotter) September 18, 2020
NEW🔥🔥 Article #IJAA @ischemo by the expert in #pkpd @jasonroberts_pk et Al
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 15, 2020
The role of antibiotic pharmacokinetic studies performed post-licensing. #IDTwitter https://t.co/jo0C3RtHDC
Created by Cameron Forbes. Last updated September 19, 2020 at 05:08 EST.